An open study of botulinum-A toxin treatment of trigeminal neuralgia
Steven R. Brenner, Bruce E. Pollock(Mayo Clinic), Bernhard Voller, H. Gemillion, David Sirois(Rutgers, The State University of New Jersey), Mark E. Linskey(University of California, Irvine), Jeffrey M. Cohen(Yale University), Joanna M. Zakrzewska(Institute of Cardiology), John F. Alksne, James A. Brown(University of Pittsburgh), Burkhard Gustorff, Eduard Auff, Gottfried Kranz, Thomas Sycha
Cited by 9
Related Papers
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
|Journal of Neuro-Oncology|2009|514
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379